• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?关于已建立细胞系中假定的癌症干细胞,一个新出现的问题是——它们是真正的干细胞还是一种波动的细胞表型?
J Cancer Stem Cell Res. 2015;3. doi: 10.14343/jcscr.2015.3e1004. Epub 2015 Feb 27.
2
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.携带乳腺癌1号基因(Brca1)的乳腺肿瘤含有具有癌症干细胞特征的不同的CD44+/CD24-细胞和CD133+细胞。
Breast Cancer Res. 2008;10(1):R10. doi: 10.1186/bcr1855. Epub 2008 Feb 1.
3
Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.癌细胞系是否具有固定或波动的干细胞表型?——以 NTera2 细胞系为例的研究。
Stem Cell Rev Rep. 2017 Oct;13(5):603-610. doi: 10.1007/s12015-017-9743-3.
4
CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells.CD44+/CD24+ 宫颈癌细胞对放疗具有抗性,并表现出癌症干细胞的特性。
Eur Rev Med Pharmacol Sci. 2016 May;20(9):1745-54.
5
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.乳腺癌干细胞标志物 CD44、CD24 和 ALDH1:内在分子亚型内的表达分布。
J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.
6
Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.表达不同干细胞标志物的乳腺癌干细胞表现出不同的生物学特性。
Mol Med Rep. 2016 Dec;14(6):4991-4998. doi: 10.3892/mmr.2016.5899. Epub 2016 Oct 27.
7
CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.CD44(高表达)CD24(低表达)分子特征决定口腔鳞状细胞癌中的癌症干细胞和上皮-间质转化表型。
Stem Cell Res. 2016 Mar;16(2):405-17. doi: 10.1016/j.scr.2016.02.028. Epub 2016 Feb 13.
8
Breast cancer stem cells and intrinsic subtypes: controversies rage on.乳腺癌干细胞与内在亚型:争议仍在激烈进行。
Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. doi: 10.2174/157488809787169110.
9
[Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].[胰腺癌干细胞中胚胎干细胞相关基因的表达改变]
Zhonghua Yi Xue Za Zhi. 2011 Nov 29;91(44):3107-10.
10
Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells.分子伴侣GRP78和GRP94在CD44(高)/CD24(低)乳腺癌干细胞中的过表达。
Bioimpacts. 2016;6(2):105-10. doi: 10.15171/bi.2016.16. Epub 2016 Jun 30.

引用本文的文献

1
models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade.白血病发展模型:极小的白血病干细胞样细胞在细胞转化级联反应中的作用
Front Cell Dev Biol. 2025 Jan 3;12:1463807. doi: 10.3389/fcell.2024.1463807. eCollection 2024.
2
(Very) Small Stem-like Cells in Human Cell Cultures.人类细胞培养中的(极)小干细胞样细胞。
Cancers (Basel). 2023 Nov 22;15(23):5520. doi: 10.3390/cancers15235520.
3
Revisiting the role of lysophosphatidic acid in stem cell biology.重新探讨溶血磷脂酸在干细胞生物学中的作用。
Exp Biol Med (Maywood). 2021 Aug;246(16):1802-1809. doi: 10.1177/15353702211019283. Epub 2021 May 26.
4
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis.癌症干细胞和机械力在卵巢癌转移中的作用
Cancers (Basel). 2019 Jul 18;11(7):1008. doi: 10.3390/cancers11071008.
5
Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.小分子威罗卡林 J 靶向肺癌干细胞自我更新途径。
Stem Cell Rev Rep. 2019 Aug;15(4):601-611. doi: 10.1007/s12015-019-09874-7.
6
IL1RL1 is dynamically expressed on Cbfb-MYH11 leukemia stem cells and promotes cell survival.IL1RL1 在 Cbfb-MYH11 白血病干细胞上动态表达,并促进细胞存活。
Sci Rep. 2019 Feb 11;9(1):1729. doi: 10.1038/s41598-018-38408-3.
7
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549.肿瘤起始能力和治疗耐药性是 NSCLC 细胞系 A549 中 EMT 相关亚群的差异特征。
Neoplasia. 2019 Feb;21(2):185-196. doi: 10.1016/j.neo.2018.09.008. Epub 2018 Dec 27.
8
Targeting Cancer Stem Cells to Overcome Chemoresistance.靶向肿瘤干细胞克服化疗耐药性
Int J Mol Sci. 2018 Dec 13;19(12):4036. doi: 10.3390/ijms19124036.
9
Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms.从干细胞和组织再生机制异常的角度看待癌症。
Leukemia. 2018 Dec;32(12):2519-2526. doi: 10.1038/s41375-018-0294-7. Epub 2018 Oct 30.
10
Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development.循环脂肪组织脂肪酸结合蛋白是肥胖相关乳腺/乳房肿瘤发生的新关联。
Cell Metab. 2018 Nov 6;28(5):689-705.e5. doi: 10.1016/j.cmet.2018.07.006. Epub 2018 Aug 9.

本文引用的文献

1
Cancer stem cells: implications for cancer therapy.癌症干细胞:对癌症治疗的启示。
Oncology (Williston Park). 2014 Dec;28(12):1101-7, 1110.
2
Is sphere assay useful for the identification of cancer initiating cells of the ovary?球体检测法对鉴定卵巢癌起始细胞有用吗?
Int J Gynecol Cancer. 2015 Jan;25(1):12-7. doi: 10.1097/IGC.0000000000000320.
3
Breast cancer and cancer stem cells: a mini-review.乳腺癌与癌症干细胞:一篇综述短文
Tumori. 2014 Jul-Aug;100(4):363-9. doi: 10.1700/1636.17886.
4
Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells.独活内酯A单独及与顺铂联合使用时,通过靶向假定的癌症干细胞来抑制卵巢癌的生长和转移。
PLoS One. 2014 Sep 29;9(9):e107596. doi: 10.1371/journal.pone.0107596. eCollection 2014.
5
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?卵巢癌干细胞:靶向治疗能否提高无进展生存期?
World J Stem Cells. 2014 Sep 26;6(4):441-7. doi: 10.4252/wjsc.v6.i4.441.
6
Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.生物活性脂质,溶血磷脂酰胆碱(LPC)和溶血磷脂酸(LPA),是新型促转移因子,其组织水平会因放疗/化疗而升高。
Mol Cancer Res. 2014 Nov;12(11):1560-73. doi: 10.1158/1541-7786.MCR-14-0188. Epub 2014 Jul 17.
7
Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.从高级别浆液性卵巢癌中分离和鉴定癌症干细胞。
Cell Physiol Biochem. 2014;33(1):173-84. doi: 10.1159/000356660. Epub 2014 Jan 24.
8
Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy.诱导肿瘤转移接受性微环境是化疗或放疗治疗的一种意想不到且被低估的副作用。
J Ovarian Res. 2013 Dec 27;6(1):95. doi: 10.1186/1757-2215-6-95.
9
CD24 and Nanog identify stem cells signature of ovarian epithelium and cysts that may develop to ovarian cancer.CD24和Nanog可识别卵巢上皮和囊肿中可能发展为卵巢癌的干细胞特征。
Acta Histochem. 2014 Mar;116(2):399-406. doi: 10.1016/j.acthis.2013.09.007. Epub 2013 Oct 6.
10
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.醛脱氢酶和 CD133 的表达定义了卵巢癌干细胞。
Int J Cancer. 2012 Jan 1;130(1):29-39. doi: 10.1002/ijc.25967. Epub 2011 Apr 8.

关于已建立细胞系中假定的癌症干细胞,一个新出现的问题是——它们是真正的干细胞还是一种波动的细胞表型?

An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?

作者信息

Gunjal Pranesh, Pedziwiatr Daniel, Ismail Ahmed A, Kakar Sham S, Ratajczak Mariusz Z

机构信息

Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.

出版信息

J Cancer Stem Cell Res. 2015;3. doi: 10.14343/jcscr.2015.3e1004. Epub 2015 Feb 27.

DOI:10.14343/jcscr.2015.3e1004
PMID:26925434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4767173/
Abstract

It has been proposed that established cell lines contain populations of cancer stem cells (CSCs), which are responsible for expansion of these cell lines and their metastatic potential. To address this issue better, we employed a human ovarian cancer cell line, A2780, and sorted cells according to the postulated highly mestatatic cancer stem cell phenotype, CD24CD44, and the less-metastatic CD24CD44 and CD24CD44 phenotypes. These cells were employed in chemotaxis assays to migrate in response to conditioned media harvested from bone marrow or liver cells damaged by irradiation and in assays to grow tumors after injection into immunodeficient mice. We also sorted single cells expressing all three phenotypes by FACS and expanded them to grow clones. We found that the CD24CD44 cells are a highly migratory population compared with CD24CD44 and CD24CD44 cells and were seeded in higher numbers in murine bone marrow and liver after intravenous injection. Most importantly, we observed that singly sorted cells efficiently expanded ex vivo into cell populations that represented all phenotypes of the parental cell line. Thus, our data indicate that cells expressing a certain set of markers, e.g., CD24, have at any given moment a higher potential to migrate and metastasize. However, cells that are CD24-negative, if expanded from a singly sorted cell, may give rise to cells containing all of the markers, including CD24. Based on this finding, we propose that the CSC phenotype in cell lines fluctuates with cell expansion.

摘要

有人提出,已建立的细胞系包含癌症干细胞(CSC)群体,这些细胞系的扩增及其转移潜能都由它们负责。为了更好地解决这个问题,我们使用了一种人卵巢癌细胞系A2780,并根据假定的高转移癌症干细胞表型CD24⁻CD44⁺以及低转移的CD24⁺CD44⁺和CD24⁺CD44⁻表型对细胞进行分选。这些细胞被用于趋化性分析,以响应从受辐射损伤的骨髓或肝细胞收获的条件培养基进行迁移,并用于在注射到免疫缺陷小鼠后进行肿瘤生长分析。我们还通过荧光激活细胞分选术(FACS)对表达所有三种表型的单细胞进行分选,并将它们扩增以形成克隆。我们发现,与CD24⁺CD44⁺和CD24⁺CD44⁻细胞相比,CD24⁻CD44⁺细胞是一个高度迁移的群体,静脉注射后在小鼠骨髓和肝脏中接种的数量更多。最重要的是,我们观察到单个分选的细胞在体外能有效地扩增为代表亲代细胞系所有表型的细胞群体。因此,我们的数据表明,表达一组特定标志物(例如CD24)的细胞在任何给定时刻都具有更高的迁移和转移潜能。然而,如果从单个分选的细胞扩增而来,CD24阴性的细胞可能会产生包含所有标志物(包括CD24)的细胞。基于这一发现,我们提出细胞系中的CSC表型会随着细胞扩增而波动。